The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Health
How worried should we be about the invasive mosquitoes in the UK?Â
News
Environment
Super El Niño could have unexpected effect on UK winter
News
Mind
Lucid dreams induced via multisensory stimulation
News
Technology
Nations and big tech to train AI using ‘gold dust’ data from Ukraine
News
Popular articles
Trending Â鶹´«Ã½ articles